Full Length Research Paper
References
|
Al-Hajje AH, Atoui F, Awada S, Rachidi S, Zein S, Salameh P (2012). Drug-related problems identified by clinical pharmacist's students and pharmacist's interventions. Ann. Pharm. Fr. 70:169-76. Crossref |
||||
|
Arroyo LA, Grana EC, Ros NB, Mero-o SR, Gil MP, Baines JPO, Payá JS (2009). Evaluación de un programa de intervención farmacéutica en pacientes con medicamentos de riesgo renal. Farm. Hosp. 33(3):147-54. Crossref |
||||
|
Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC (2012). Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch. Gerontol. Geriatr. 54(1):168-74. Crossref |
||||
| Comitê de Consenso (2007). Tercer Consenso de Granada sobre Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos Asociados a la Medicación (RNM). Ars. Pharm. 48:5-17. | ||||
| Conde CA, Aquerreta I, Eslava AO, Zamarbide OG, Deiró JG (2006). Impacto clínico y economico de la incorporación del farmacéutico residente en el equipo asistencial. Farm. Hosp. 30:147-54. | ||||
|
Elliot RA, Martinac G, Campbell S, Thorn J, Woodward MC (2012). Pharmacist-led medication review to identify medication-related problems in older people referred to an aged care assessment team: a randomizes comparative study. Drugs Aging 29:593-605. Crossref |
||||
| Farré Riba R, Clópes Estela A, Sala Esteban M, Castro Cels, I, Gámez Lechuga M, López Sánchez S, Tomás Sanz R. Alba Aranda G, Castillo Álvarez F, García Peláez M, Montejo Arcusa O, Serra Soler G, Sanz Mazó M (2000). Intervenciones farmacéuticas (parte I): metodología y evaluación. Farm. Hosp. 24(3):136-44. | ||||
| Farrell B, Ward N, Dore N, Russel G, Geneau R, Evans S (2012). Working in interprofessional primary health care teams: what do pharmacists do? Res. Social Adm. Pharm. 1:1-14. | ||||
| Gandhi PJ, Smith BS, Tataronis GR, Maas B (2001). Impact of a pharmacist on drug cost in a coronary care unit. Am. J. Health-Syst. Pharm. 55:497-503. | ||||
| García NI, Jané CC, Creus MT, Dalmau LM, Vila RG, Sala JR (2002). Evaluación de la integración del farmacêutico em equipos de atención de unidades de hospitalización. Farm. Hosp. 24:18-27. | ||||
|
Hanlon JT, Lindblad CI, Gray SL (2004). Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am. J. Geriatr. Pharmacother. 2:3-13. Crossref |
||||
|
Hepler CD, Strand LM (1990). Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 47:533-43. Pubmed |
||||
|
Jiang SP, Zheng X, Li X, Lu XY (2012). Effectiveness of pharmaceutical care in an intensive care unit from China: a pre- and post-intervention study. Saudi Med. J. 33:756-62. Pubmed |
||||
|
López IM, Pazo-Oubi-a F, Vilardell PL (2011). Atención farmacêutica integral a los pacientes de um servicio de Cirurgía Vascular. Farm. Hosp. 35:260-3. Crossref |
||||
| Nunes PHC, Pereira BMG, Nominato JCS, Albuquerque EM, Silva LFN, Castro IRS, Castilho SR (2008). Intervenções farmacêuticas e prevenção de efeitos adversos. Rev. Bras. Ciênc. Farm. 44(4):691-9. | ||||
| Organização Panamericana De Saúde (OPAS) (2002). Consenso brasileiro de atenção farmacêutica: proposta. Atenção Farmacêutica no Brasil: Trilhando Caminhos. Brasília, Organização Pan-Americana da Saúde. | ||||
|
Soria MALM, Marti MC, Torres NVJ (2011). Aceptación de recomendaciones en el paciente con oportunidades de mejora farmacoterapéutica. Farm. Hosp. 35:51-7. Crossref |
||||
| Torner MQG, Estradé EO, Solernou FP (2003). Atención farmacêutica en lós problemas relacionados com lós medicamentos em enfermos hospitalizados. Farm. Hosp. 27:280-89. | ||||
| World Health Organization (WHO) (2012). Anatomical Therapeutic Chemical Classification (ATC Code), 2012. Available at: <http://www.whocc.no/atcddd> Accessed 21st August 2012. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
